Sec. 4004. REAUTHORIZATION; REPORTING REQUIREMENTS
257 words·~1 min read·
/statute-compilations/comps-17191/sec-4004A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 4004 REAUTHORIZATION; REPORTING REQUIREMENTS Section 744I of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-53) is amended— ####
(1)in subsection (a)(1), by striking “Beginning with fiscal year 2018, not” and inserting “Not”; ####
(2)by striking “Biosimilar User Fee Amendments of 2017” each place it appears and inserting “Biosimilar User Fee Amendments of 2022”; ####
(3)in subsection (a)(2), by striking “Beginning with fiscal year 2018, the” and inserting “The”; ####
(4)in subsection (a)(3)(A), by striking “Not later than 30 calendar days after the end of the second quarter of fiscal year 2018, and not later than 30 calendar days after the end of each quarter of each fiscal year thereafter” and inserting “Not later than 30 calendar days after the end of each quarter of each fiscal year for which fees are collected under this part”; ####
(5)in subsection (b), by striking “Not later than 120 days after the end of fiscal year 2018 and each subsequent fiscal year for which fees are collected under this part” and inserting “Not later than 120 days after the end of each fiscal year for which fees are collected under this part”; ####
(6)in subsection (c), by striking “Beginning with fiscal year 2018, and for” and inserting “For”; and ####
(7)in subsection (f)— #####
(A)in paragraph (1), in the matter preceding subparagraph (A), by striking “fiscal year 2022” and inserting “fiscal year 2027”; and #####
(B)in paragraph (3), by striking “January 15, 2022” and inserting “January 15, 2027”.
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 4004
REAUTHORIZATION; REPORTING REQUIREMENTS
Cites 1Cited by 0 across 0 sources